cupure logo
AstraZeneca in Talks for Potential $400 Billion Merger with Bristol Myers Squibb

AstraZeneca in Talks for Potential $400 Billion Merger with Bristol Myers Squibb

AstraZeneca is reportedly in discussions for a potential merger with Bristol Myers Squibb, a deal that could create one of the world's largest pharmaceutical companies valued at approximately $400 billion.

Comments

Read this story in other languages

Covered by the press in 5 countries

Among the outlets we follow

  • Spain4
  • Germany3
  • United Kingdom3
  • Italy2
  • France1

Similar News from External Sources

How we write our stories →

Cupure writes the day's most important stories in seven languages. The name comes from the French 'coupure de journal' — a newspaper clipping — our promise of concise, relevant news.

For advertising inquiries, content suggestions, or to flag a concern about a news item or content, you can reach us. We value your feedback. Contact form